Tower Research Capital »

Rigel Pharmaceuticals shares owned by Tower Research Capital

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $124k 15k 8.22

More positions owned by Tower Research Capital

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)
Netflix (NFLX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Adobe Systems Incorporated (ADBE)

View all positions for Tower Research Capital

Top funds holding Rigel Pharmaceuticals

Armistice Capital
BlackRock
BlackRock
Morgan Stanley
Invesco
Soleus Capital Management
Vanguard Group
Susquehanna International
Assenagon Asset Management
Acadian Asset Management
Geode Capital Management
State Street Corporation
Stonepine Capital Management
CM Management
Ing Investment Management

View all funds holding Rigel Pharmaceuticals